db/db mice are a model of obesity and diabetes due to their lack of functional leptin receptors, which leads to insulin resistance, elevated corticosterone levels, and persistent inflammation. Because stress-induced elevations in glucocorticoids sensitize microglia to immune challenges, we hypothesized that corticosteroids might act similarly in the diabetic brain. To test this hypothesis, db/db and wildtype mice were treated with the glucocorticoid synthesis inhibitor metyrapone every day for 2 weeks. This treatment revealed corticosterone-dependent increases in microglial number and accumulation of the pro-inflammatory cytokines interleukin 1beta and tumor necrosis factor alpha in the hippocampus of db/db mice. Analysis of microglial responses to lipopolysaccharide stimulation revealed that glucocorticoids lower the threshold for release of pro-inflammatory cytokines, underscoring the role of corticosteroids as a precipitating factor for neuroinflammation in obesity and diabetes.
Introduction
While there is significant consensus that obesity, and the metabolic consequences of obesity, involves activation of peripheral immune responses (Kanneganti and Dixit, 2012) , the extent to which these responses extend to the brain is unclear. Given that the central nervous system is thought to be protected from the circulating immune milieu by the blood-brain barrier, the question of whether neuroinflammation accompanies peripheral immune activation in obesity has received little attention until recently. Several groups have now reported increases in the number and reactivity of microglia, the resident macrophages of the brain, in hypothalamic nuclei that mediate food intake and metabolism (Thaler et al., 2010) . However, neural changes in obesity and its endocrine comorbidities are not confined to circuits traditionally associated with ingestive behavior and glycemic control. Imaging studies (Falvey et al., 2013) and longitudinal studies of cognition (Xu et al., 2010) have reliably demonstrated structural atrophy in the medial temporal lobe and behavioral impairment on tests of learning and memory in individuals with obesity and diabetes. Although mechanistic data are somewhat scarce, the literature surrounding cognitive and synaptic impairment in rodent models of obesity and diabetes suggests that exposure to chronic elevations in adrenal steroid hormones could contribute to memory deficits (Stranahan et al., 2008a) . Taken together, these converging lines of evidence suggest that diabetes and obesity impair cognition, in part by elevating corticosterone levels, but the neuroimmune consequences of manipulating corticosterone have yet to be addressed.
Glucocorticoids are thought to blunt inflammatory responses, based on the consequences of acute exposure to cortisol, corticosterone, and other synthetic corticosteroids. In the context of protracted exposure, such as that which occurs in chronic stress, anti-inflammatory effects are reversed, and glucocorticoids convert from anti-inflammatory to pro-inflammatory (Sorrells et al., 2009 ). These observations rest primarily on data from studies of psychological stress (Frank et al., 2007) and direct administration of exogenous adrenal steroids (Frank et al., 2012) . Given that the endocrine and immune profile in obesity and diabetes differs from that of normoglycemic individuals, the extent to which perturbation of adrenal steroid hormones in obesity and diabetes might elicit central nervous system inflammation in this context remains uncertain.
In these experiments, we used a genetic mouse model of obesity and diabetes arising from leptin receptor deficiency (db/db mice) that exhibits chronically elevated corticosterone levels. db/db mice develop hyperglycemia and insulin resistance during the early postnatal period (Timmers et al., 1986) , and also exhibit increased circulating corticosterone concentrations 5 to 6 weeks after birth (Takeshita et al., 2000) . We administered the corticosterone synthesis inhibitor metyrapone for 2 weeks, beginning at 6 weeks of age to prevent the development of hypercortism, and measured levels of pro-inflammatory cytokines in the hippocampus. We quantified hippocampal microglia with unbiased stereology, and assessed microglial reactivity ex vivo following LPS stimulation. These analyses revealed that, similar to psychogenic stressors, diabetes and obesity-induced elevations in corticosterone mediate hippocampal neuroinflammation and microgliosis. These effects E-mail address: astranahan@gru.edu (A.M. Stranahan). 1 These authors contributed equally.
